Adults 18 to younger than 65 years of age living with overweight or obesity may qualify for a clinical research study evaluating an investigational once-weekly GLP-1/GIP injection for weight management.
Adults 18 to younger than 65 years of age living with overweight or obesity may qualify for a clinical research study evaluating an investigational once-weekly GLP-1/GIP injection for weight management.
Adults 18 to younger than 65 years of age living with overweight or obesity may qualify for a clinical research […]
A vaccine research study is expected to open for enrollment in the coming weeks. Join our notification list to be […]
Researchers are studying an investigational medication to see how effective it may be as a potential weight reduction treatment. If […]
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]